» Articles » PMID: 23052212

A SAXS-based Ensemble Model of the Native and Phosphorylated Regulatory Domain of the CFTR

Overview
Publisher Springer
Specialty Biology
Date 2012 Oct 12
PMID 23052212
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR), the defective protein in cystic fibrosis, is an anion channel activated by protein kinase A phosphorylation. The regulatory domain (RD) of CFTR has multiple phosphorylation sites, and is responsible for channel activation. This domain is intrinsically disordered, rendering the structural analysis a difficult task, as high-resolution techniques are barely applicable. In this work, we obtained a biophysical characterization of the native and phosphorylated RD in solution by employing complementary structural methods. The native RD has a gyration radius of 3.25 nm, and a maximum molecular dimension of 11.4 nm, larger than expected for a globular protein of the same molecular mass. Phosphorylation causes compaction of the structure, yielding a significant reduction of the gyration radius, to 2.92 nm, and on the maximum molecular dimension to 10.2 nm. Using an ensemble optimization method, we were able to generate a low-resolution, three-dimensional model of the native and the phosphorylated RD based on small-angle X-ray scattering data. We have obtained the first experiment-based model of the CFTR regulatory domain, which will be useful to understand the molecular mechanisms of normal and pathological CFTR functioning.

Citing Articles

Role of Protein Kinase A-Mediated Phosphorylation in CFTR Channel Activity Regulation.

Della Sala A, Prono G, Hirsch E, Ghigo A Front Physiol. 2021; 12:690247.

PMID: 34211404 PMC: 8240754. DOI: 10.3389/fphys.2021.690247.


Predicting Conformational Properties of Intrinsically Disordered Proteins from Sequence.

Ruff K Methods Mol Biol. 2020; 2141:347-389.

PMID: 32696367 DOI: 10.1007/978-1-0716-0524-0_18.


Changes in the R-region interactions depend on phosphorylation and contribute to PKA and PKC regulation of the cystic fibrosis transmembrane conductance regulator chloride channel.

Poroca D, Amer N, Li A, Hanrahan J, Chappe V FASEB Bioadv. 2020; 2(1):33-48.

PMID: 32123855 PMC: 6996395. DOI: 10.1096/fba.2019-00053.


Digested disorder: Quarterly intrinsic disorder digest (January/February/March, 2013).

Uversky V Intrinsically Disord Proteins. 2017; 1(1):e25496.

PMID: 28516015 PMC: 5424799. DOI: 10.4161/idp.25496.


Molecular modelling and molecular dynamics of CFTR.

Callebaut I, Hoffmann B, Lehn P, Mornon J Cell Mol Life Sci. 2016; 74(1):3-22.

PMID: 27717958 PMC: 11107702. DOI: 10.1007/s00018-016-2385-9.


References
1.
Lewis H, Buchanan S, Burley S, Conners K, Dickey M, Dorwart M . Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J. 2003; 23(2):282-93. PMC: 1271750. DOI: 10.1038/sj.emboj.7600040. View

2.
Kanelis V, Hudson R, Thibodeau P, Thomas P, Forman-Kay J . NMR evidence for differential phosphorylation-dependent interactions in WT and DeltaF508 CFTR. EMBO J. 2009; 29(1):263-77. PMC: 2808376. DOI: 10.1038/emboj.2009.329. View

3.
Neville D, Rozanas C, Price E, Gruis D, Verkman A, Townsend R . Evidence for phosphorylation of serine 753 in CFTR using a novel metal-ion affinity resin and matrix-assisted laser desorption mass spectrometry. Protein Sci. 1998; 6(11):2436-45. PMC: 2143598. DOI: 10.1002/pro.5560061117. View

4.
Dalton J, Kalid O, Schushan M, Ben-Tal N, Villa-Freixa J . New model of cystic fibrosis transmembrane conductance regulator proposes active channel-like conformation. J Chem Inf Model. 2012; 52(7):1842-53. DOI: 10.1021/ci2005884. View

5.
Alexander C, Ivetac A, Liu X, Norimatsu Y, Serrano J, Landstrom A . Cystic fibrosis transmembrane conductance regulator: using differential reactivity toward channel-permeant and channel-impermeant thiol-reactive probes to test a molecular model for the pore. Biochemistry. 2009; 48(42):10078-88. PMC: 2765204. DOI: 10.1021/bi901314c. View